Fan Zhang
ORCID：0000-0003-3726-5478
发表论文 27 篇 · 总被引 499 次 · h-index 9
代表论文
- Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial (2024 · Nature Medicine · 被引 130)
- Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959) (2019 · BMC Medicine · 被引 101)
- Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: A multicenter, retrospective cohort study (2024 · American Journal of Transplantation · 被引 61)
- Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors (2020 · Frontiers in Immunology · 被引 55)
- Patterns, treatments, and prognosis of tumor recurrence after resection for hepatocellular carcinoma with microvascular invasion: a multicenter study from China (2021 · HPB · 被引 35)
- Comparing treatment outcomes of concurrent chemoradiotherapy with or without nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinoma (2018 · Cancer Biology & Therapy · 被引 30)